Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients
Alex Ganetsky(Hospital of the University of Pennsylvania), David Porter(University of Pennsylvania), Daria V. Babushok(Hospital of the University of Pennsylvania), Cheryl Gilmar(Hospital of the University of Pennsylvania), Selina M. Luger(University of Pennsylvania), James K. Mangan(UC San Diego Health System), Mindy G. Schuster(Unknown), Edward A. Stadtmauer(University of Pennsylvania), Saar Gill(Parker Institute for Cancer Immunotherapy), Alison W. Loren(University of Pennsylvania), Craig W. Freyer(Hospital of the University of Pennsylvania), Mitchell E. Hughes(Hospital of the University of Pennsylvania), Jennifer Han(University of Pennsylvania), Noelle V. Frey(Hospital of the University of Pennsylvania), Elizabeth O. Hexner(University of Pennsylvania), Mary Ellen Martin(University of Pennsylvania)
Cited by 79
Related Papers
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)
|Clinical Infectious Diseases|2010|1.5k